PKM and urogenital neoplasm: SNO-PKM2, a validated SCoR2 substrate, protects against ischemic kidney injury and endothelial damage (Siragusa et al., 2019) via increased flux through the PPP shunt (Zhou et al., 2019; Zhou et al., 2023b).